The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · May 2017
Randomized Controlled Trial Multicenter Study Comparative StudyMaintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial.
Maintenance therapy improves outcomes in various tumour types, but cumulative toxic effects limit the choice of drugs. We investigated whether maintenance therapy with vinflunine would delay disease progression in patients with advanced urothelial carcinoma who had achieved disease control with first-line chemotherapy. ⋯ Pierre-Fabre Médicament.